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Paternal heterochromatin formation in human
embryos is H3K9/HP1 directed and primed by
sperm-derived histone modiﬁcations
Christine van de Werken1, Godfried W. van der Heijden1,2, Cindy Eleveld1, Miriam Teeuwssen1,
Mareike Albert3,w, Willy M. Baarends2, Joop S.E. Laven1, Antoine H.F.M. Peters3,4 & Esther B. Baart1
The different conﬁgurations of maternal and paternal chromatin, acquired during oogenesis
and spermatogenesis, have to be rearranged after fertilization to form a functional embryonic
genome. In the paternal genome, nucleosomal chromatin domains are re-established after the
protamine-to-histone exchange. We investigated the formation of constitutive hetero-
chromatin (cHC) in human preimplantation embryos. Our results show that histones carrying
canonical cHC modiﬁcations are retained in cHC regions of sperm chromatin. These modiﬁed
histones are transmitted to the oocyte and contribute to the formation of paternal embryonic
cHC. Subsequently, the modiﬁcations are recognized by the H3K9/HP1 pathway maternal
chromatin modiﬁers and propagated over the embryonic cleavage divisions. These results are
in contrast to what has been described for mouse embryos, in which paternal cHC lacks
canonical modiﬁcations and is initially established by Polycomb group proteins. Our results
show intergenerational epigenetic inheritance of the cHC structure in human embryos.
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F
ertilization marks the fusion of two specialized gametes—
oocyte and sperm. In mammalian zygotes, the maternal and
paternal genomes exist in an asymmetric chromatin
conﬁguration. Extensive reorganization of chromatin to the
embryonic conﬁguration is crucial for the developmental
potency1. During this process, some information of parental
origin needs to be retained to maintain imprinting2. Other
chromatin domains, such as the constitutive heterochromatin
(cHC), need to be reorganized to the somatic conﬁguration to
function properly3,4.
Constitutive HC assembles mostly on telomeric, centromeric
and pericentric regions, remains condensed throughout the cell
cycle and is important for genome stability and chromosome
segregation5. DNA sequences underlying cHC differ between
species, but mainly consist of repeats and transposons. In
mouse, most of the cHC is located pericentrically (pericentric
heterochromatin (pHC)), a region with major satellite DNA
repeats. In human, cHC is more dispersed across the genome6;
classic satellite II and III DNA repeats localize to the pericentric
region, but also to large blocks of cHC on chromosomes 1, 9,
16, the acrocentric chromosomes and Y7, also referred to as
‘knobs’5.
The H3K9/HP1 pathway underlies the formation of cHC. A
central event is the trimethylation of histone H3 at lysine 9
(H3K9me3) by histone methyltransferases (HMTs) Suv39h1 and
Suv39h2 (refs 5,8,9). H3K9me3 serves as a docking place for the
binding of heterochromatin protein 1 (HP1) isoforms, which
results in chromatin compaction5. Subsequently, HP1 binds
Suv4-20h1/2 HMTs, which trimethylate histone H4 at lysine 20
(H4K20me3) to further establish a compact chromatin
structure5,10. Through an unidentiﬁed mechanism, H3K9me3
also facilitates the trimethylation of histone H3 at lysine 64
(H3K64me3), which has been suggested to stabilize cHC11,12. The
H3K9/HP1 pathway is interwoven with the methylation of
DNA, another mechanism for gene silencing prominent in
cHC5,10. Together, all modiﬁcations eventually lead to the
establishment of a condensed, transcriptionally repressed state
that is epigenetically heritable through cell division.
In mammalian oocytes, the maternal genome is marked by
high levels of histone lysine methylation, whereas in spermatozoa
the paternal genome is compacted with small proteins named
protamines13. Current knowledge of resolution of this epigenetic
asymmetry in early mammalian embryos is mainly based on
mouse models1. Paternal pHC in mouse spermatozoa and zygotes
is largely devoid of canonical cHC marks14. Re-establishment of
the canonical pHC conﬁguration is not performed by the H3K9/
HP1 pathway. Instead, during the earliest embryonic stages,
maternally provided Polycomb repressive complex 1 (PRC1)
localizes to paternal pHC, which subsequently becomes enriched
for Polycomb repressive complex 2 (PRC2)-mediated
trimethylation of histone H3 on lysine 27 (H3K27me3) (refs
3,15). The core PRC1 complex contains an E3 ligase Ring1a/b,
which interacts with one of the orthologues of the Drosophila
posterior sex combs (Mel18, Bmi1 or Nspc1), a Polyhomeiotic
orthologue (Phc1, Phc2 or Phc3) and a Polycomb orthologue
(Cbx2, Cbx4, Cbx6, Cbx7 or Cbx8) (ref. 16). The PRC2 core
complex contains one of the HMTs, Ezh1 or Ezh2, together with
the regulatory subunits Suz12 and Eed17. In somatic cells,
Polycomb complexes are known to regulate the formation of
facultative heterochromatin, a type of heterochromatin that is
able to undergo changes in conﬁguration in the context of
regulation of gene expression. Thus, in mouse preimplantation
embryos, the paternal pericentric DNA temporarily assumes a
facultative heterochromatin packaging, to circumvent the
inactivity of the H3K9/HP1 pathway. The PRC1/2 pathway
thereby operates as a transient backup mechanism for pHC
formation3. During the eight-cell stage of mouse embryo
development, the H3K9/HP1 pathway takes over again and the
pHC of both parental origins gradually becomes equivalent
for H3K9me3 (refs 3,18). Other pHC-associated marks,
such as H3K64me3 and H4K20me3, remain undetected in the
paternal chromatin until after compaction and implantation,
respectively11,12,19.
In this study, we addressed chromatin dynamics on cHC
during human preimplantation embryo development. Our results
identify striking differences with mouse: cHC in human embryos
is not re-established by PRC1/2 action, but is transmitted and
maintained by actors of the canonical H3K9/HP1 pathway. We
show that human spermatozoa retain and transmit nucleosomes
with cHC marks, such as H3K9me3, to the embryo. These
paternal marks are subsequently bound by maternal HP1 and
propagated over cell divisions. On the basis of this, we propose a
model in which paternal cHC is transmitted intergenerationally.
Results
Pronuclear cHC localization in human zygotes. To determine
the localization of cHC in human zygotes, pronuclear morphol-
ogy was studied. Due to restrictions on the use of human embryos
for research, we were limited to tripronuclear (3PN) zygotes and
embryos resulting from 3PN zygotes to study embryos at
Embryonic day (E) 1 and 2 (for overview of stages and source of
embryos, see Supplementary Fig. 1a). Tripronuclear zygotes
mostly originate from an oocyte that is fertilized by two sper-
matozoa, resulting in one maternal pronucleus and two paternal
pronuclei20. Occasionally, when polar body extrusion fails, a 3PN
zygote contains two maternal pronuclei and one paternal
pronucleus. 3PN zygotes proceed through the ﬁrst divisions
normally and are capable of implantation, thus providing an
ethically acceptable and relevant model for the ﬁrst stages of
preimplantation embryo development21,22. From E3 onwards,
embryos developed from diploid (2PN) zygotes and donated for
research were used (Supplementary Fig. 1a).
Pronuclear morphology of human zygotes differs from mouse
zygotes. In late-stage mouse zygotes (G2 phase, also indicated as
PN4/5 stage23), pronuclei are spherical and the DNA is spread
throughout the pronucleus. A 40-6-diamidino-2-phenylindole
(DAPI)-intense ring-like structure around the nucleolar
precursor body (NPB) contains the pHC3,4 (Fig. 1a). Human
pronuclei also appear spherical under a stereomicroscope
(Fig. 1b). However, when pronuclei are examined at G2 phase
(18–20 h after fertilization24, Supplementary Fig. 1a) by DNA
staining, the DNA content concentrates in the direction of the
opposing pronucleus in both live and ﬁxed conditions, resulting
in a crescent shape (Fig. 1c,d). The NPBs are also contained in
DAPI-rich ring-like structures, but are smaller and more
numerous when compared with mouse NPBs at that stage. In
addition, a few DAPI-rich knobs are observed, similar in
appearance to cHC blocks in human somatic cells5. Using
human autoantibodies against the centromeres (ACA), we show
that the centromeres are situated in close proximity to both the
rings and knobs (Fig. 1d). This conﬁrms that these DAPI-rich
chromatin domains are located pericentrically and are likely to
contain cHC in human embryos.
PRC1/2 are not associated with cHC in cleavage stages. Protein
localization of PRC1 and PRC2 subunits was performed by
immunoﬂuorescence in 3PN zygotes ﬁxed at G2 phase. The
enzymatic PRC1 subunit RING1B was not detected (Fig. 2a),
whereas typical RING1B foci25 were observed in nuclei from
hU2OS cells and human blastocysts (Supplementary Fig. 2a).
Similar results were obtained for two other PRC1 subunits,
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RING1A and PHC2 (Supplementary Fig. 2b,c), as well as for the
core components of PRC2, EZH2 (Fig. 2b) and EED
(Supplementary Fig. 2d).
Subsequently, we characterized PRC2 activity by investigating
the histone modiﬁcation it catalyses—H3K27me3. Immunodetec-
tion of H3K27me3 in 3PN zygotes at the G2 phase revealed a
clear asymmetry for H3K27me3 staining, with one pronucleus
showing intense staining throughout, whereas in the other two
pronuclei staining levels were barely detectable (Fig. 2c). These
results are in accordance with our previous ﬁndings20 and those
of Zhang et al.26 Since metaphase II chromosomes in oocytes
show high levels of H3K27me3 (ref. 26) and in analogy to what
has been described in mouse15,27 and other species28,29, we
propose the pronucleus with strong H3K27me3 staining to be of
maternal origin.
In mouse zygotes, paternal pHC becomes increasingly enriched
for H3K27me3 by PRC2 activity during G2 phase3,30. In contrast,
in human zygotes arrested at the prometaphase stage, H3K27me3
levels remained barely detectable on paternal chromosomes, also
at pericentric regions (Fig. 2d). To determine whether PRC2
activity is upregulated during subsequent development, we
performed immunostaining on whole-mount embryos of all
stages of preimplantation development from the zygote at E1 to
the blastocyst at E5 (for overview of stages and source of embryos
see Supplementary Fig. 1a). On E1 and E2, H3K27me3 staining
was restricted to one side of the nucleus, presumably marking the
maternal chromatin. Overall levels of H3K27me3 decreased to
become barely detectable at E3. From E4 onwards, H3K27me3
levels increased and the staining was distributed throughout the
entire nucleus (Fig. 2e). To exclude differences caused by the
triploid state of the embryos examined at E1 and E2, we
compared embryos at E3 and E4 developed from normal,
dipronuclear zygotes (Fig. 2e) with those developed from 3PN
zygotes (Supplementary Fig. 2e) and observed no differences. The
lack of PRC2 activity at E1–3 is thus unlikely to be related to the
triploid state of the embryos investigated.
Next we analysed the abundance of mRNA transcripts for
subunits of PRC1 and PRC2 by quantitative PCR with reverse
transcription (RT–qPCR) in oocytes and embryos of eight
developmental stages (for overview of stages, see Supplementary
Fig. 1a). The mRNA expression of most PRC1 and PRC2 subunits
followed similar patterns throughout preimplantation develop-
ment: levels decreased from oocytes to the eight-cell stage at E3
and increased again from E3.5 onwards (Supplementary Fig. 3a),
concomitant with the above-described increase in trimethylation
levels of H3K27.
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Figure 1 | Pronuclear morphology of human zygotes differs from mouse zygotes. (a) Representative confocal image of a mouse zygote ﬁxed 12–15 h post
fertilization (G2 phase) with typical pronuclear morphology as observed by DNA staining (DAPI; n¼ 10). Shown is a full projection of Z-sections. Pronuclei
contain a ring-like structure called NPB and pHC can be observed as a ring with intense DAPI staining, surrounding the NPB. Paternal (#) and maternal
(~) pronuclei are indicated, as is the polar body (pb). Scale bar, 10mm. (b) Stereo micrograph of a human 3PN zygote showing typical pronuclear
morphology. Detail shows a magniﬁcation of the boxed area. Scale bar, 20mm. (c) Representative confocal image of a human zygote 18–20 h post
insemination (G2 phase) with typical pronuclear morphology as observed by live staining with Hoechst 33342 (n¼6). Shown are three projections of
consecutive Z-sections through the three pronuclei. DNA inside each pronucleus is contracted into a crescent shape containing several ring-like structures
and denser stained ‘knobs’. Detail shows a magniﬁcation of a single Z-section through the boxed ring-like structure with attached knob (arrow). Scale bar,
10mm. (d) Representative confocal image of a human zygote ﬁxed 18–20h post insemination (G2 phase) with typical pronuclear morphology (n¼ 10).
Shown is a full projection of Z-sections with DNA staining (DAPI; blue) and immunolocalization of the centromeres (ACA; white). Pronuclear morphology
is not affected by ﬁxation and DNA is observed in the same crescent shape with ring-like structures and DAPI-intense knobs (arrows). Centromeres
are localized preferentially on the ring or in close proximity to a knob. Details 1 and 2 show the magniﬁcations of a single Z-section through the boxed
ring-like structure and knob, respectively. Scale bar, 10mm.
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Although observed high levels of H3K27me3 on maternal
chromatin indicates PRC2 activity at some point during the
oocyte development, our failure to detect PRC1 and PRC2 at the
paternal chromatin suggests the absence of these complexes in the
zygote and the early embryo. Alternatively, our observations can
also be explained by the inability of PRC complexes to target
paternal chromatin. To differentiate between these possibilities,
we injected human spermatozoa into mouse oocytes, resulting in
heterologous zygotes (Supplementary Fig. 1b). When ﬁxed at late
G2 phase, the human paternal pronucleus was observed to have
adopted a mouse-like pronuclear morphology. We detected
Ring1b staining at the ring surrounding the NPBs (Fig. 2f). This
shows that the mouse maternal Ring1b is able to access human
paternal chromatin. When heterologous zygotes were arrested
and ﬁxed at prometaphase, H3K27me3 was detected in a banding
pattern on human paternal chromatin in heterologous zygotes
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(Fig. 2g). This is in contrast to barely detectable levels on paternal
prometaphase chromosomes in human zygotes (Fig. 2d). These
results indicate that human sperm chromatin is intrinsically able
to undergo PRC1/2 processing. Although we cannot completely
rule out the possibility that the observed change in pronuclear
structure positively affects the accessibility of paternal cHC in
heterologous zygotes, the low abundance of PRC1 and PRC2
transcripts and the dilution of maternal H3K27me3 over divisions
suggests an absence of active PRC1/2 in early human embryos.
Altogether our results suggest that the PRC1/2 pathway does not
have a role in paternal cHC establishment in human preimplan-
tation embryos.
H3K9me3 marks paternal chromatin on DAPI-rich regions. As
the PRC1/2 pathway does not seem to be involved in the build-up
of cHC in early human embryos, we investigated the canonical
H3K9/HP1 pathway by immunostaining for H3K9me3. In
human 3PN zygotes at the late G2 phase, maternal pronuclei are
abundantly marked by H3K9me3, as described before20 (Fig. 3a).
Although the signal in the paternal pronuclei was overall much
lower, we did observe strong enrichment of H3K9me3 at the
DAPI-rich knobs (Fig. 3a). This parental asymmetry in H3K9me3
was conﬁrmed by the staining of prometaphase chromosome
spreads: on paternal chromosomes, enrichment was detected
between the centromeres and on a few chromosome bands
(Fig. 3b).
Next we investigated if our observations for H3K9me3 on the
paternal chromatin in post-S-phase human zygotes resulted from
the de novo H3K9 methyltransferase activity during S-phase. In
B10% of in vitro fertilized (IVF) oocytes that fail to fertilize after
IVF, a sperm cell has penetrated, but failed to activate the
oocyte31. Such spermatozoa frequently undergo a condensation of
the paternal chromatin into chromatids, called premature
chromatid condensation (PCC). In oocytes with sperm-PCC,
we detected strong H3K9me3 enrichment on paternal chromatids
at pericentric regions and heterochromatic knobs (Fig. 3c),
indicating that this mark is independent of DNA replication in
S-phase.
To determine the fate of H3K9me3 on paternal chromatin in
the zygote, we performed immunostaining of H3K9me3 on
whole-mount embryos of all stages of preimplantation develop-
ment (Supplementary Fig. 1a). In nuclei from E1 and E2 embryos,
H3K9me3 staining was restricted to one side of the nucleus,
presumably marking the maternal chromatin (Fig. 3d). In
contrast to H3K27me3, levels on maternal chromatin remained
high during these stages and DAPI-rich domains in the paternal
chromatin remained positive for H3K9me3. From the eight-cell
stage on, H3K9me3 was detected throughout the nucleus at
DAPI-rich domains (Fig. 3d). These ﬁndings were conﬁrmed by
H3K9me3 staining of prometaphase chromosomes of eight-cell
(E3) embryos arrested at the prometaphase stage of the fourth
cleavage division; the difference between maternal and paternal
chromosomes was no longer obvious (Fig. 3e). Taken together,
these results show that H3K9me3 marks the paternal cHC in the
zygote and suggest that this modiﬁcation is maintained during
subsequent cleavage divisions.
H3K9me3 marks satellite DNA repeats in human spermatozoa.
In mouse spermatogenesis, pHC becomes devoid of H3K9me3 as
elongation is completed and the mark is also not detected on the
paternal chromatin in the zygote directly after fertilization14,27.
However, in human spermatozoa, H3K9me3 enrichment has
been observed at the pericentric region of chromosome 16 using
chromatin immunoprecipitation-PCR32. To further investigate
the presence of H3K9me3 in mature human spermatozoa, we
performed the immunolocalization of H3K9me3 and the
centromeres (ACA) after in vitro decondensation. In virtually
all spermatozoa, H3K9me3 was prominently detected around the
centromeres (Fig. 4a). To investigate the location of retained
H3K9me3 in more detail, human spermatozoa were subjected to
extreme in vitro decondensation to obtain sperm chromatin in a
ﬁbre-like conﬁguration. Whereas H3 was detected broadly,
H3K9me3 was detected directly around the centromere,
conﬁrming its pericentric localization (Fig. 4b).
In mouse elongating spermatids, pHC domains that still
contain residual H3K9me3-bearing nucleosomes also become
enriched for nucleosomes with acetylation of histone H4
(refs 14,33). Although these modiﬁcations appear to be
mutually exclusive at the nucleosome level, pHC temporarily
exists in a bivalent state that may contribute to the
reprogramming process33. To investigate if cHC in mature
human spermatozoa exists in a similar bivalent state, H4
acetylation was detected by immunoﬂuorescence. Acetylation of
lysines 5, 8 and 12 of histone H4 (H4K5ac, H4K8ac and
H4K12ac) as well as a tetra-acetylated form of H4 (H4ac4)
localized in a cap-like pattern, as described for human elongating
spermatids34 (Supplementary Fig. 4). In contrast to mouse, the
acetylated forms of H4 were not speciﬁcally enriched around the
centromeres and H4K12ac was not conﬁned to the H3K9me3-
positive pHC domains (Fig. 4c).
Figure 2 | PRC1 and PRC2 are not associated with paternal cHC in cleavage stage human embryos. (a–c) Representative confocal images of human 3PN
zygotes ﬁxed at G2 phase. Shown are full projections of Z-sections. (a,b) Zygotes immunostained with PRC1 subunit RING1B (n¼ 10) and PRC2 subunit
EZH2 (n¼ 5) antibodies (green). No signal is observed to localize to the pronuclei. Scale bars, 30mm. (c) Immunolocalization of H3K27me3 (green) in a
3PN zygote (n¼ 15). Paternal (#) and maternal (~) pronuclei are indicated. H3K27me3 is detected broadly on maternal chromatin and only very low levels
are observed on paternal chromatin with no enrichment at DAPI-intense, heterochromatic rings or knobs (arrows). Scale bar, 10mm. (d) Representative
chromosome spread of a 3PN zygote (n¼ 5) arrested at prometaphase showing immunolocalization of H3K27me3 (green) and centromeres (ACA; white).
Paternal (#) and maternal (~) chromosomes are indicated. H3K27me3 is detected broadly on maternal chromosomes and no H3K27me3 enrichment is
observed in the paternal pericentric regions. Scale bar, 10mm. (e) Representative full projections of confocal Z-sections of human embryos at indicated
stages (n¼ 5–10 per embryonic stage). From embryonic day (E) 1 to 3, nuclei show an asymmetric staining pattern for H3K27me3 (green). Compared with
the overall H3 levels as detected by a histone H3 antibody (white), H3K27me3 levels decrease gradually with each cell division. At E4, H3K27me3 is clearly
detected throughout all nuclei. Arrows indicate the polar body, where H3K27me3 remains high. Detail shows a magniﬁcation of the boxed nucleus. Scale
bars, 30 mm. (f) Mouse oocytes injected with human spermatozoa, ﬁxed at PN4/5 stage (G2 phase). Shown is a representative confocal image of
immunolocalization of Ring1b (green) in a heterologous zygote (n¼ 30). Human paternal (#) and mouse maternal (~) pronuclei are indicated. The human
paternal pronucleus assumes a mouse-like morphology and Ring1b is detected at distinct regions on the DAPI-intense ring around the nucleolar precursor
bodies. Scale bar, 10mm. (g) Representative chromosome spread from a heterologous zygote (n¼ 5) arrested at prometaphase with immunolocalization of
H3K27me3 (green). Human paternal (#) and mouse maternal (~) chromosomes are indicated. On human paternal chromosomes, H3K27me3 is detected
and shows enrichment at distinct chromosome bands. Scale bars, 10mm.
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To investigate if human DNA repeat sequences underlying
cHC are marked by H3K9me3 in sperm cells, we performed a
combination of immunoﬂuorescent analysis of H3K9me3 and
ﬂuorescent in situ hybridization (immuno-FISH). We investi-
gated a-satellite repeats located on chromosomes 7 and X and Sat
II/III sequences of chromosomes 1, 9, 16 and Y. With the
exception of the X a-satellite, all repeat sequences investigated
were observed to localize partially or completely to the region
enriched for H3K9me3 in the majority of sperm cells investigated
(Fig. 4e,f, Supplementary Fig. 5). These results demonstrate that
DNA repeat sequences that form the cHC in humans are
enriched for H3K9me3 in sperm cells. To investigate if this is also
the case after fertilization, we performed immuno-FISH on
sperm-PCC in unfertilized oocytes and on paternal chromosomes
3P
N
 z
yg
ot
e
H
3K
9m
e3
D
N
A
M
er
ge
E1.5 (3PN) E2 (3PN) E3 (2PN) E5 (2PN)E4 (2PN)
DNA H3K9me3 Merge
D
et
ai
l
DNA H3K9me3 ACA Merge
3P
N 
zy
go
te
Merge incl maternal set
E3
 (2
PN
)
DNA H3K9me3 ACA Merge
Detail
Detail
Detail w/o DNA
DNA H3K9me3
0P
N 
PC
C
ACA Merge Detail
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6868
6 NATURE COMMUNICATIONS | 5:5868 | DOI: 10.1038/ncomms6868 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
of human zygotes arrested at prometaphase (Fig. 4g). Probe
signals for Sat II and III sequences on chromosomes 1, 9, 16 and
Y were observed to consistently co-localize with the H3K9me3-
positive regions. The satellite III repeat region located to the knob
on the long arm of the Y chromosome is completely marked by
H3K9me3.
Thus, the DNA repeat sequences underlying cHC are enriched
for H3K9me3 on paternal chromatin before and after fertilization.
This suggests the delivery of these sequences in a canonical,
heterochromatic conformation from the spermatozoon to the
embryo.
Sperm contributes modiﬁed histones marking cHC to zygotes.
Instead of the suggested inheritance of modiﬁed histones, our
ﬁndings might also be explained by a scenario wherein paternally
inherited nucleosomes are replaced by maternal ones, which are
subsequently modiﬁed by maternal SUV39H1/2 activity. In
mouse oocytes, the Suv39h-mediated modiﬁcation of H3K9 is not
active on paternal cHC3. Any H3K9me3 observed on human
paternal chromatin after heterologous ICSI in mouse oocytes
would thus be of sperm origin. First we injected heat-inactivated
human spermatozoa (for experimental set-up of hetero-
logous ICSI, see Supplementary Fig. 1b), which have lost the
ability to activate the oocyte35 and directly undergo PCC after
injection. In mouse oocytes with human sperm-PCC, we detected
distinct H3K9me3-rich regions on the human paternal
chromatids (Fig. 5a), identical to sperm-PCC in human oocytes
(Fig. 3c). Next we injected normal human spermatozoa
(Supplementary Fig. 1b) and investigated zygotes at the late G2
phase. The human paternal pronucleus exhibited distinct
domains of H3K9me3 on the DAPI-rich rings around the
NPBs (Fig. 5b), whereas this mark is absent from mouse paternal
chromatin at this stage3. PRC1 is not targeted to the H3K9me3-
positive domains, as these two types of heterochromatin do not
overlap on both PCC and the paternal pronucleus at G2
(Fig. 5a,b). This reinforces the previous ﬁndings that H3K9me3
impairs PRC1 targeting3. In heterologous zygotes arrested at
prometaphase, the H3K9me3 staining pattern was similar to
the one observed on human 3PN zygotes. Distinct H3K9me3-
positive bands were observed on human paternal chromosomes
(Fig. 5c). Chromosome morphology of these heterologous
spreads was generally good, and in some cases allowed (partial)
karyotyping based on chromosome size and DAPI-
banding pattern (Fig. 5d). Strong enrichment of H3K9me3
on heterochromatin knobs was speciﬁcally observed on
chromosomes 1, 9, 13, 14, 16, 21 and Y, on regions known to
contain satellite II and III DNA repeats.
Altogether these data suggest that the H3K9me3 in human
spermatozoa is retained during the remodelling that occurs in a
mouse oocyte after gamete fusion. On the basis of our previous
observations36 and the data we presented here, we assume this
also to be the case in human zygotes. Therefore, our results
indicate a sperm origin of these modiﬁed histones in paternal
embryonic chromatin.
Maternal machinery reads and maintains paternal cHC. As
described, the H3K9me3-binding HP1 proteins (isoforms a and
b) and histone modiﬁcations H4K20me3 and H3K64me3 are
additional markers of cHC. To investigate the extent of cHC
formation on the paternal chromatin, we determined the
dynamics of these additional markers by immunoﬂuorescent
analysis in spermatozoa, unfertilized oocytes with PCC, 3PN
zygotes and all stages of preimplantation development. As
described in mouse3, we also failed to detect HP1b in in vitro
decondensed human spermatozoa (data not shown). However, in
contrast to mouse, both HP1a and HP1b were readily detected at
the DAPI-rich knobs in paternal pronuclei, co-localizing with
H3K9me3 (Fig. 6a and Supplementary Fig. 6a). HP1b dynamics
during embryo development followed the same pattern as
H3K9me3, with asymmetric staining in the nucleus at E1 and
E2 (Fig. 6d and Supplementary Fig. 7a). From E3 onwards,
staining was observed at DAPI-rich regions throughout the
nucleus.
H4K20me3 was detected around the centromeres in decon-
densed human spermatozoa, similar to H3K9me3. After fertiliza-
tion, H4K20me3 was detected ubiquitously in the maternal
chromatin, on DAPI-rich knobs at G2 phase in the paternal
pronucleus and in the paternal pericentric regions in PCC and
prometaphase chromosomes (Fig. 6b and Supplementary Fig. 6b).
From the two-cell stage onwards, H4K20me3 remained detectable
in a pattern similar to H3K9me3, but staining appeared more
constricted to the DAPI-rich regions (Fig. 6d and Supplementary
Fig. 7a).
H3K64me3 was observed at barely detectable levels in
decondensed human spermatozoa. In unfertilized oocytes with
paternal PCC, H3K64me3 was detected strongly in the maternal
chromatin, but barely in the paternal chromatin. H3K64me3
levels appeared to increase after S-phase, as staining was
observed on DAPI-rich knobs at G2 phase in the paternal
pronucleus and prometaphase chromosomes (Fig. 6c and
Figure 3 | H3K9me3 is detected on DAPI-dense regions in paternal chromatin from cleavage stage human embryos. (a) Representative confocal image
of a human 3PN zygote ﬁxed at G2 phase (n¼ 15). Shown is a full projection of Z-sections with immunolocalization of H3K9me3 (red). Paternal (#) and
maternal (~) pronuclei are indicated. H3K9me3 is detected broadly on maternal chromatin and on paternal chromatin enrichment of H3K9me3 is detected
at DAPI-intense, heterochromatic, regions (arrows). Detail shows a magniﬁcation of the boxed region. Scale bar, 10mm. (b) Representative chromosome
spread of a 3PN zygote arrested at prometaphase (n¼ 30) showing the immunolocalization of H3K9me3 (red) and centromeres (ACA; white). Paternal
(#) and maternal (~) chromosomes are indicated. H3K9me3 is detected broadly on maternal chromosomes. On paternal chromosomes, H3K9me3 is
observed at inner centromeric regions (arrows) and some distinct chromosome bands (arrows). Detail shows a magniﬁcation of the boxed chromosomes.
Scale bar, 10mm. (c) Representative chromosome spread of a human oocyte 18–20 h post insemination with fertilization failure (0PN) and presence of
paternal chromatids after PCC (n¼ 10). Shown is the immunolocalization of H3K9me3 (red) and centromeres (ACA; white) on paternal chromatids.
H3K9me3 is detected at distinct regions around the centromeres. Detail shows a magniﬁcation of the boxed chromatid (arrows indicate examples of the
pericentromere and a H3K9me3 enriched band). Scale bar, 10mm. (d) Representative full projections of confocal Z-sections of human embryos at indicated
stages (n¼ 5–10 per embryonic stage). On embryonic day (E) 1.5 and E2, H3K9me3 (red) is detected in an asymmetric pattern similar to the zygote.
Levels on maternal chromatin remain high and arrows indicate H3K9me3 enriched regions on paternal chromatin. From E3 onwards, H3K9me3 was
detected throughout the nucleus. Detail shows a magniﬁcation of the boxed nucleus. Scale bars, 30mm. (e) Representative chromosome spread of an
embryo at E3.5 arrested at the prometaphase of the fourth cleavage division with immunolocalization of H3K9me3 (red) and centromeres (ACA; white)
(n¼ 5). H3K9me3 was detected in a banding pattern on all chromosomes with enrichment at pericentric regions. Detail shows a magniﬁcation of the boxed
chromosomes. Scale bar, 10mm.
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Supplementary Fig. 6b). From the two-cell stage onwards,
H3K64me3 followed a pattern similar to H4K20me3 (Fig. 6e
and Supplementary Fig. 7b).
These ﬁndings show that, in contrast to mouse, paternal cHC
in human preimplantation stage embryos contains a full suite of
canonical cHC markers, all of them grouped in the H3K9/HP1
pathway. Since we found that maternal HP1 binds sperm-derived
H3K9me3 and that H3K64me3 is increased at H3K9me3-positive
regions, our data also show that the modiﬁed histones
contributed by the sperm cell enable further establishment and
maintenance of cHC by the maternal machinery.
Discussion
The current work identiﬁes three major mechanistic differences
in paternal cHC build-up between mouse and human: (1) human
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paternal cHC is transmitted from the spermatozoon to the zygote
in a canonical conformation, which is subsequently propagated
by the H3K9me3/HP1 pathway, (2) in humans, paternal
embryonic cHC remains under control of the H3K9/HP1
pathway and cHC is characterized by hallmarks as H4K20me3
and H3K64me3 much earlier in development than in mouse and
(3) a PRC1/2-mediated back-up mechanism, as described in
mouse3, does not seem to play a role.
On the basis of our results, we propose an intergenerational
model for cHC build-up in the early human embryo (Fig. 7):
nucleosomes bearing H3K9me3 and H4K20me3 are
transmitted by the spermatozoon and demarcate cHC domains
in the zygote. H3K9me3 is detected and bound by maternally
provided HP1 proteins, which in turn bind the SUV39H1/2
and SUV4-20H1/2 KMTs, enabling the propagation of these
marks. Low levels of H3K64me3 present in the sperm cell
can contribute to the feedback loop that reinforces further
heterochromatinization12. Together this results in the epigenetic
propagation of the chromatin conformation of paternal cHC to
the next generation.
In mouse, only 1% of sperm DNA remains histone
associated37. Although transferred to the embryo14, this low
quantity of paternally inherited nucleosomes might not allow
similar protein-based inheritance of heterochromatic DNA.
Instead, paternal heterochromatic build-up is initiated through
action of PRC1 (ref. 3). Recent ﬁndings indicate that the histone
demethylase Kdm2b binds to unmethylated CpG islands and
directly recruits a subset of PRC1 complexes to chromatin in
pluripotent stem cells38. This or an analogous binding cascade
could enable a DNA-based paternal heterochromatin build-up in
mouse embryos38,39. Thus, whereas mouse embryos seem to
depend on sperm DNA sequence and a maternal store of
Polycomb proteins to re-establish paternal cHC, in human
embryos cHC is inherited from the sperm cell in the canonical
conﬁguration.
In mouse, Polycombs are key to regulation of genes associated
with development40. Therefore, our failure to detect PRC1/2
activity in human cleavage stage embryos is remarkable.
However, immunoﬂuorescence is not sensitive enough to detect
possible presence and maintenance of H3K27me3 at a gene level.
Genome-wide chromatin analysis of human sperm cells
previously identiﬁed H3K27me3 enrichment at developmental
regulators32,41. If transferred to the embryo in a similar fashion as
H3K9me3, these marks might be enough to prevent inappropriate
gene expression. A global decline in H3K27me3 levels during
preimplantation development has also been described in bovine
and porcine cleavage embryos, in which the embryonic stage with
the lowest levels of H3K27me3 coincided with EGA42. Our
ﬁndings are consistent with this, as the major wave of human
EGA occurs around the eight-cell stage43. The global loss of
H3K27me3 may thus be required for EGA in species where EGA
occurs later than in mouse42.
In mouse embryos, the transcription of major satellites,
especially from the paternal genome, has recently been reported
to be crucial for rearrangement of pHC4. In this light, it is
interesting that we observed strong H3K9me3 enrichment on
satellite II/III DNA repeats on paternal chromatin in both
spermatozoa and zygotes. Sat III repeat sequences are primate
speciﬁc44 and long non-coding Sat III transcripts have been
implicated in developmental regulation45. As long non-coding
RNAs contribute to heterochromatin assembly during female X
chromosome inactivation, Sat III transcripts may have a similar
function in cHC maintenance46. It remains to be determined if
such RNA-based mechanisms are needed for cHC organization in
human embryos or if the self-sustaining loop of the full H3K9/
HP1 pathway is sufﬁcient.
During mammalian spermiogenesis, histones are replaced by
protamines. In humans, 5–15% of the DNA, encompassing
speciﬁc genes, as well as (peri)centromeric DNA, appear to be
protected against this removal and retain a nucleosomal structure
(for review, see ref. 47). Studies on human sperm have
demonstrated that there is an increase in the nucleosome/
protamine ratio when sperm from male factor subfertility patients
are compared with sperm from fertile men, conﬁrming
incomplete chromatin remodelling during spermatid
elongation48. Also, differences in the composition of retained
nucleosomes exist between these groups, with a more dispersed
pattern throughout the genome in sperm from subfertility
patients41,48–50. As we show that sperm-inherited modiﬁed
histones contribute to cHC formation in the human zygote, the
variability observed in the retention of nucleosomes may interfere
with cHC function in the zygote and impact on embryo
developmental potential.
Frequently, the ﬁndings on chromatin dynamics in early mouse
embryos are assumed to be universal for epigenetic reprogram-
ming in mammalian embryos51,52. Our ﬁndings highlight the
existence of divergent epigenetic developmental programs in
mammals. Charting these differences will greatly improve our
understanding of how heterochromatin features impact on
embryo development.
Figure 4 | H3K9me3 marks satellite DNA sequences at cHC regions on paternal chromatin in spermatozoa and zygotes. (a) Representative confocal
image of a human in vitro decondensed spermatozoon. Shown is a full projection of Z-sections with the immunolocalization of H3K9me3 (red) and
centromeres (ACA; white) (n¼ 100). Enrichment of H3K9me3 surrounding centromeres suggests pericentric localization. Dotted line indicates the nucleus
of the spermatozoon. Scale bar, 10mm. (b) Representative immunoﬂuorescent image of human spermatozoa subjected to extreme in vitro decondensation.
Chromatin contained in a nucleosomal structure was identiﬁed using a histone H3 antibody (green), in combination with immunolocalization of H3K9me3
(red) and centromeres (ACA; white) (n¼ 100). H3K9me3 is detected directly neighbouring ACA signal, indicating pericentric localization. Scale bar,
20mm. (c) Full projection of Z-sections of a human in vitro decondensed spermatozoon with immunolocalization of H3K9me3 (red) and H4K12ac (green)
(full set of single-channel images in Supplementary Fig. 4). Graph shows the distribution of ﬂuorescent intensities along the line (c) for H3K9me3 (red) and
H4K12ac (green) in arbitrary units. (d) Codetection of H3K9me3 (red) and (peri)centric repeat sequences (white) in in vitro decondensed human
spermatozoa (n¼ 10–12) by immuno-FISH. DNA probes detecting satellite (Sat) DNA II/III repeat sequences at heterochromatic knobs on chromosomes 1,
9, 16 and Y and a satellite DNA sequences at centromeric locations (chromosomes 7 and X) are used. Shown are the representative merged images of a
single Z-section through the probe signal (full set of single-channel images in Supplementary Fig. 5). Graph shows the distribution of ﬂuorescent intensities
along the line for H3K9me3 (red) and probe signal (grey) in arbitrary units. Scale bar, 5mm. (e) Distribution of sperm cells according to their classiﬁcation
based on their proﬁles shown in d. (f) Codetection of H3K9me3 and (peri)centric repeat sequences by immuno-FISH on chromosome spreads. Upper
panel: representative chromosome spread from the paternal chromosome set of a 3PN zygote arrested at prometaphase hybridized with DNA probes
detecting satellite II/III sequences at chromosomes 1 (1qh, red) and 9 (9qh, green) (n¼ 5). Lower panel: representative chromosome spread from paternal
chromatids (PCC) in an unfertilized oocyte (0PN; n¼ 7) hybridized with DNA probes detecting satellite II/III sequences at chromosomes 16 (16qh, red)
and Y (yqh, green). DNA probes co-localize with areas of strong H3K9me3 (white) enrichment. Scale bars, 10mm.
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Methods
Collection and culture of human gametes and embryos. All human surplus
material was donated for research according to guidelines of the local ethical
committee. Surplus embryos and oocytes were donated with patients’ written
informed consent after approval by the Dutch Central Committee on Research
Involving Human Subjects (CCMO—NL28739.000.09).
Ovarian stimulation, oocyte retrieval, IVF procedures and assessment of
embryo morphology were performed as described53. Supernumerary good-quality
embryos were cryopreserved. Cryopreservation was performed in a controlled rate
freezer (in straws in culture medium with 1.5M dimethyl sulfoxide. Straws were
cooled to  6 C before seeding and subsequently cooled to  40 C at
0.3 Cmin 1. Finally, the straws were cooled rapidly at  25 Cmin 1 to
 140 C, before immersion in liquid nitrogen and storage in nitrogen vapour.
After donation for research, thawing of embryos was performed at room
temperature by consecutive washes in decreasing dimethyl sulfoxide concentrations
in G-MOPS Plus medium (Vitrolife).
Oocytes that failed to fertilize after IVF (0PN) were obtained 18 h post
insemination at embryonic day (E) 1. Tripronuclear (3PN) embryos were used to
study embryo development from E1 to E2. Surplus cryopreserved preimplantation
embryos of good quality were used to study embryonic developmental stages from
E3 to E5 (for overview of stages, see Supplementary Fig. 1a). Embryo culture
was performed in G1 Plus medium (Vitrolife) from E1 to E3 and thereafter in G2
Plus medium (Vitrolife) according to the manufacturer’s instructions. Human
surplus spermatozoa were obtained from IVF patients meeting the criteria for
normospermia (WHO, 2010). These sperm samples underwent routine workup by
layering on a discontinuous silica gel gradient (PureSperm, Nidacon International)
and centrifugation at 1,100 r.p.m. for 20min. The resulting pellet was washed with
G-IVF Plus medium (Vitrolife) at 1,600 r.p.m. for 10min and kept in 0.5ml G-IVF
at 37 C, 6% CO2 in air.
Human U2OS cells (a gift from Dr Kops54) were grown in Dulbecco’s Modiﬁed
Eagle’s Medium (Sigma) supplemented with 10% fetal bovine serum (Sigma) and
100Uml 1 penicillin, 100 mgml 1 streptomycin (Invitrogen) and cultured at
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Figure 5 | H3K9me3 on paternal embryonic chromatin originates from the human spermatozoon. To assess the origin of H3K9me3 on human paternal
chromatin, human spermatozoa were injected into mouse oocytes. (a) Confocal analysis of ﬁxed mouse oocytes 22 h after heterologous ICSI with heat-
inactivated human sperm (n¼ 30). Shown is a full projection of Z-sections containing paternal chromatids (#) with immunolocalization of H3K9me3 (red)
and Ring1b (green). H3K9me3 is clearly detected at pericentric regions on each chromatid. Scale bar, 10mm. (b) Representative confocal image of the
paternal pronucleus of a heterologous zygote ﬁxed 12–15 h after injection (G2 phase; n¼ 30). Shown is a full projection of Z-sections with
immunolocalization of H3K9me3 (red) and Ring1b (green). The human paternal pronucleus (#) assumes a mouse-like morphology (PN4). H3K9me3 and
Ring1b are detected in a non-overlapping fashion at distinct regions at the DAPI-intense ring around the nucleolar precursor bodies. Detail shows a
magniﬁcation of the boxed ring. Scale bar, 10mm. (c,d) Representative chromosome spread of a zygote resulting from heterologous ICSI arrested at
prometaphase (n¼ 30). Paternal (#) and maternal (~) chromosomes are indicated. Scale bars, 10mm. (c) Mouse maternal chromosomes with
immunolocalization of H3K9me3 (red), showing H3K9me3 ubiquitously on maternal chromosomes. (d) On paternal chromosomes, the immuno-
localization of H3K9me3 (red) and centromeres (ACA; white) revealed enrichment of H3K9me3 at the inner centromere of all chromosomes. Partial
karyotyping of the paternal chromosomes identiﬁed strong enrichment on heterochromatin knobs on chromosomes 1, 9, 13, 14, 21 and Y. Chromosomes 16,
17 and 22 were not unambiguously identiﬁed in this spread.
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37 C in a humidiﬁed chamber in the presence of 5% CO2. Cells were plated on
poly-D-Lysine-coated 12-mm coverslips, ﬁxed with methanol at  20 C for 10min
and then permeabilized with 0.2% Triton-X-100 in PBS.
Antibodies. The following antibodies were used: rabbit polyclonal antibodies
against H3K9me3 (1:500; Abcam ab8898), tetra-acetyl-Histone H4 (1:100; Upstate
06-598), H4K5ac (1:500; Abcam ab51997), H4K8ac (1:500; Upstate, 06-760),
H4K12ac (1:500; Upstate 06-761), H4K20me3 (1:500 (ref. 55)), H3K64me3 (1:20
(ref. 11)) and H3K27me3 (1:200 (ref. 55)), mouse monoclonal antibodies against
RING1A (1:200; Millipore 05-1362), RING1B (1:400 (ref. 56)), PHC2 (1:50
(ref. 57)), EZH2 (undiluted (ref. 58)), EED (undiluted (ref. 58)), HP1a (1:500;
Euromedex 2HP-1H5-AS) and H3 (1:1,000; Active Motif 39763); rat monoclonal
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antibodies against H4K12ac (1:50; SciLight Biotechnology C2077001) and HP1b
(1:500; Serotec MCA1946); and human anti-centromere antibodies (ACA; human
centromere antiserum; 1:1,000, Fitzgerald Industries).
Primary antibodies were detected by labelling with the appropriate secondary
antibodies conjugated with Alexa Fluor 488, 555, 594 or 633 (Invitrogen).
Fixation and immunoﬂuorescence of embryos. After removal of the zona pel-
lucida by incubation with Acidic Tyrode’s Solution (Sigma), embryos were washed
twice in G-MOPS, ﬁxed for 15min in 4% paraformaldehyde (PFA) in PBS (pH 7.4)
and permeabilized with 0.2% Triton-X-100 in PBS for 15min at room temperature.
Embryos were incubated in blocking solution (0.1% Tween-20 in PBS containing
2% bovine serum albumin (BSA) and 5% normal goat serum) for 4 h at room
temperature, followed by incubation with primary antibodies in blocking solution
overnight at 4 C. Embryos were washed three times for 20min in 0.1% Tween-20
in PBS containing 2% BSA before application of secondary antibodies. These were
diluted 1:200 in blocking solution and embryos were incubated for 1 h at room
temperature, followed by three washing steps in 0.1% Tween-20 in PBS containing
2% BSA. Double antibody stainings were performed by mixing appropriate pri-
mary antibodies for simultaneous incubation, followed by detection with different
secondary antibodies. Embryos were mounted on coverslips with Vectashield with
750 ngml 1 DAPI for DNA counterstaining (Vector Laboratories)3.
For live staining of DNA in 3PN zygotes, zygotes were incubated in medium
containing 1 mgml 1 Hoechst 33342 and imaged directly.
To obtain chromosome spreads, embryos were incubated with 1.5 mgml 1
colcemid (Invitrogen) for 8–16 h to arrest cells at prometaphase. After zona
pellucida removal, arrested embryos were incubated in hyposolution (25% fetal calf
serum in 0.5% sodium citrate) for 5min and subsequently transferred to a drop of
ﬁxative (1% PFA with 0.2% Triton-X-100, pH 9.2) on a glass slide. After horizontal
drying for 1 h, slides were washed with 0.08% Photo-Flo (Kodak) and air dried59.
Slides with chromosome spreads were stored at  20 C until use. Surface spread
preparations were processed for immunoﬂuorescence as described above without
permeabilization.
For each embryonic stage and antibody investigated, ﬁve to ten embryos were
analysed unless otherwise stated.
Single oocyte and embryo RT–qPCR. mRNA levels were quantiﬁed in single
oocytes and preimplantation embryos at the following eight developmental stages:
metaphase II oocytes (E0; n¼ 7); zygotes (E1; n¼ 5); two-cell embryos (E1.5;
n¼ 5), four-cell (E2; n¼ 4), eight-cell (E3; n¼ 5), 12–16 cell (E3.5; n¼ 5), morula
(E4; n¼ 4) and blastocyst (E5; n¼ 5; Supplementary Fig. 1a). Human embryonic
stem cells (WA01 (H1) Lot 11, WiCell Research Institute) were used as a control.
For RT–qPCR of single oocyte/embryos, the Taqman PreAmp Cells-to-Ct Kit
(Applied Biosystems) was used according to the manufacturer’s protocol with minor
adjustments21. The zona pellucida was removed from the oocytes and embryos by
incubation in 0.1% protease (Sigma) in G-MOPS medium for 3min, before
washing in G-MOPS medium and PBS. Lysis was performed for 5min in 20ml of
Taqman PreAmp Cells-to-Ct lysis solution and terminated by addition of 2ml of stop
solution. After 2min of incubation the lysate was stored at  20 C until further
processing within 1 week. Small pieces of human embryonic stem cell colonies
containing 500–1,000 cells were washed in PBS and transferred to 50ml Taqman
PreAmp Cells-to-Ct Lysis solution and terminated by addition of 5ml stop solution.
RNA was reverse transcribed to cDNA within an hour at 37 C by adding 25ml
of 2 RT Buffer and 2.5ml of 20 RT Enzyme Mix to each lysate, before
inactivating the enzyme for 5min at 95 C. For sequence-speciﬁc preampliﬁcation of
cDNA, Taqman Gene Expression Assays (Assays-on-demand, Applied Biosystems)
were pooled and diluted 1:100 with 1 TE buffer (10mM Tris–HCl, 5mM
EDTA; pH 7.5) to a ﬁnal concentration of 180nM of each primer. The following
assays (Applied Biosystems) were used: ZP3 (Assay ID: Hs00610623_m1, amplicon
size: 74 bp), HPRT1 (Hs99999909_m1, 100bp), SOX2 (Hs01053049_s1, 91 bp), OCT4
(Hs00999632_g1, 77 bp), BMI1 (Hs00180411_m1, 105 bp),MEL18 (Hs00810639_m1,
64bp), RING1A (Hs00968517_m1, 71 bp), RING1B (Hs00200541_m1, 82bp), PHC2
(Hs00189460_m1, 114 bp), CBX2 (Hs00364145_m1, 93 bp), CBX7 (Hs00545603_m1,
54bp), CBX8 (Hs00221034_m1, 64 bp), EZH1 (Hs00157470_m1, 65 bp), EZH2
(Hs00544830_m1, 86bp), and EED (Hs00537777_m1, 110 bp). Assays were selected
to be exon spanning and to recognize most of the validated (Ref Seq) splice variants of
each gene of interest.
To 12.5 ml of cDNA, 25ml of Taqman PreAmp Master Mix and 12.5 ml of 0.2
pooled Taqman Gene Expression Assays were added. After 10 cycles of
preampliﬁcation (10min at 95 C, followed by 10 15 s at 95 C and 4min at
60 C), the preampliﬁed cDNA (50ml) was diluted with 100ml of 0.5 TE buffer.
qPCR was performed on an ABI Prism 7000 Sequence Detecting System (Applied
Biosystems) using 10ml of 2 Taqman Gene Expression Master Mix, 1 ml of
Taqman Gene Expression Assay and 5 ml of nuclease-free water added to 4 ml of
diluted preampliﬁed cDNA. The two-step cycling parameters were as follows: one
cycle of 2min at 50 C, followed by one cycle of 10min at 95 C to activate the
polymerase and 40 cycles of 15 s at 95 C and 1min at 60 C (ref. 21). Results were
analysed using Sequence Detection Software version 1.2.3 (Applied Biosystems)
and expressed as cycle threshold values (Supplementary Fig. 3a). As a
preampliﬁcation reaction of 10 cycles was performed, the detection limit of the
qPCR was set at a cycle threshold value of 30 or less. Presence of a single PCR-
product of expected amplicon size was veriﬁed by 2% agarose gel electrophoresis
(Supplementary Fig. 3b).
Heterologous intra cytoplasmic sperm injection. All institutional and national
guidelines for the care and use of laboratory animals were followed and mouse
experiments were approved by the local committee on animal experiments, DEC
Consult. B6D2 F1 female mice (Harlan) were used as oocyte donors and super-
ovulation was induced by intraperitoneal injection of 7.5 IU pregnant mare’s serum
gonadotrophin (Intervet) followed by 7.5 IU human chorionic gonadotropin
(Intervet) 48 h later60,61. Oocytes were isolated from the oviducts 13 h after human
chorionic gonadotropin and cumulus cells were removed by brief incubation in
G-MOPS medium containing 80 IUml 1 hyaluronidase (Sigma). Thereafter, the
oocytes were washed and kept until after injection in freshly prepared mem-alpha
medium (Life Technologies), supplemented with 10% (v/v) fetal calf serum, 21 mM
HEPES, 12.2 mM sodium lactate, 1 mM sodium pyruvate and 1 mM L-glutamin.
Microinjection was performed using an inverted microscope equipped with an ICSI
micromanipulation set-up (Narishige) and a piezo-actuated injector (Burleigh). A
XYclone laser system (Hamilton Thorne) was used to breach the zona pellucida.
Before installation, a small volume of mercury (Sigma) was inserted in an Straight
Piezo Drill Micropipette (Humagen). Spermatozoa were used either directly after
collection from the epididymis or, to prevent oocyte activation, after heat
inactivation (incubation at 50 C for 30min (ref. 62)). For each injection series, an
aliquot of spermatozoa was transferred to medium containing 12% polyvinyl
pyrrolidone (Irvine Scientiﬁc). Spermatozoa were immobilized with a short piezo
pulse applied to the neck piece. Injections were performed at room temperature.
Injected oocytes were warmed to 37 C and transferred after 5–10min to G1
medium (Vitrolife) for culture at 37 C, 5% CO2 in air. Oocytes injected with heat-
inactivated spermatozoa (n¼ 60) were ﬁxed 22 h after injection with 4% PFA as
described above. Oocytes injected with normal spermatozoa were either ﬁxed with
4% PFA 12–15 h after injection (n¼ 60) or transferred to medium containing
1.5 mgml 1 colcemid and processed for chromosome spreads 7–9 h later as
described above (n¼ 60).
In vitro sperm decondensation. Sperm head decondensation was achieved as
described48, with some modiﬁcations. First, 5 ml of a spermatozoa suspension was
brought on a glass slide and spread out using the side of the pipet tip. After drying,
Figure 6 | Paternal cHC marked by H3K9me3 also contains HP1b, H4K20me3 and H3K64me3. (a) Representative confocal image of a human 3PN
zygote ﬁxed 18–20h post insemination with immunostaining of H3K9me3 (red) and HP1b (white) (n¼ 5). Paternal (#) and maternal (~) pronuclei are
indicated. Detail shows a magniﬁcation of the boxed region. HP1b was detected broadly on the maternal pronucleus and on heterochromatin knobs on the
paternal pronucleus (arrows and detail), co-localizing with H3K9me3 staining. Scale bar, 10mm. (b,c) Representative merged confocal images of a human
in vitro decondensed spermatozoon, a human 0PN oocyte with PCC, a human 3PN zygote at G2 phase and a human 3PN zygote arrested at prometaphase
(n¼ 5–10 per embryonic stage), all immunostained for (b) H4K20me3 (red) and centromeres (ACA; white (excluding G2 phase)) or (c) H3K64me3 (red)
and centromeres (ACA; white (excluding G2 phase)). Shown are full projections of Z-sections. Paternal (#) and maternal (~) chromatin is indicated.
Details show the magniﬁcations of boxed regions. Full set of single-channel images in Supplementary Fig. 5. Both H4K20me3 and H3K64me3 were
detected at pericentric regions in all stages, comparable to H3K9me3 and HP1b, but H3K64me3 staining was less intense in spermatozoa and 0PN PCC.
(d,e) Dynamics of H4K20me3, HP1b and H3K64me3 during human preimplantation embryo development. Representative merged confocal images of
human embryos at indicated developmental stages (n¼ 5–10 per embryonic stage) with immunolocalization of (d) H4K20me3 (red) and HP1b (white) or
(e) H3K64me3 (red). Shown are the representative merged full projections of confocal Z-sections. Detail shows magniﬁcation of the boxed nucleus. Full set
of single-channel images in Supplementary Fig. 6. On embryonic day (E) 1 and E2, all antibodies are detected in an asymmetric pattern similar to their
expression the zygote. On condensed chromosomes, paternal H3K64me3 knobs are clearly visible (arrow). Whereas HP1b is observed strongly and
throughout the nucleus from E3 onwards, H4K20me3 and H3K64me3 are more conﬁned to DAPI-intense regions.
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the slides were incubated in decondensation buffer (2.5mM dithiothreitol (Sigma),
0.2% Triton-aX-100 (Sigma) in PBS) for 10min, followed by incubation for 3, 4
and 5min with 0.5% (v/v) heparin (5,000Uml 1, LEO Pharma BV) in
decondensation buffer. Subsequently, the slides were ﬁxed in 4% PFA for 15min,
air dried, washed in Photo-Flo and air dried. Slides were processed for
immunoﬂuorescence immediately as described above, starting with two washes in
PBS-T. For each sperm sample, the optimal decondensation time was determined
by sperm head morphology and ACA antibody accessibility. Preparations with
optimal decondensation were used for further analysis. The presence of each
histone modiﬁcation under investigation was assessed in at least 100 sperm cells
with clearly distinguishable ACA staining, from at least three separate donors.
To obtain sperm DNA in a chromatin ﬁbre-like structure, 5 ml of spermatozoa
suspension was added to 80 ml decondensation buffer, as described above and
incubated for 10–20min. Heparin was added to a concentration of 0.5% (v/v) and
incubated for 10min. Of this decondensed spermatozoa suspension, 5 ml was
brought on a glass slide, spread out using the side of the pipet tip and air dried.
Slides were ﬁxed in 4% PFA for 15min and processed for immunoﬂuorescence as
described above.
Immunoﬂuorescence—FISH. For immuno-FISH on in vitro decondensed sper-
matozoa, slides were ﬁrst processed for FISH. The DNA probes used were Satellite
DNA II/III probes for chromosomes 1 (pUC1.77 (ref. 63)), 9 (pHuR98 (refs
64,65)), 16 (pHuR195 (refs 64,65)) and Y (RPN1305X (ref. 66)), and alpha satellite
DNA probes for chromosomes 7 (pa7tl (ref. 67)) and X (pBamX5 (ref. 68)). Probes
were ﬂuorescently labelled using a BioPrime DNA labelling kit (Invitrogen),
according to the manufacturer’s instructions. A hybridization mixture containing
1 ng ml 1 of labelled probe in 50% formamide, 10% dextran sulfate, 1% Tween-20
and 0.1 mgml 1 Human Cot-1 DNA (Invitrogen) in 2 standard saline citrate
(SSC) was applied to each slide under a coverslip. Slides were denatured at 75 C
for 3min and hybridization was performed in a humid box at 37 C for 6 h. After
hybridization, slides were washed in 2 SSC/0.05% Tween-20 for 2min at 42 C,
0.4 SSC for 6min at 60 C and in 2 SSC/0.05% Tween-20 for 2min at room
temperature. The slides were rinsed once in PBS before proceeding to
immunoﬂuorescence of H3K9me3 as described above. Immuno-FISH was imaged
simultaneously and for each probe co-localization for H3K9me3 and satellite DNA
was measured in 10–12 randomly selected sperm cells from at least three separate
donors.
For immuno-FISH on chromosome spreads of unfertilized oocytes or 3PN
zygotes (ﬁve to seven per probe combination), slides were ﬁrst processed for
immunoﬂuorescence of H3K9me3 as described above. Chromosome spreads were
subsequently imaged and positions of chromosomes were recorded in the form of
the XY-position of the microscope table. These coordinates were used to ﬁnd the
same chromosomes after FISH. Subsequently, FISH was performed as described69
for either Satellite DNA II/III probes for chromosome 1 (pUC1.77 (ref. 63)) in
combination with 9 (pHuR98 (refs 64,65)) or 16 (pHuR195 (refs 64,65)) in
combination with Y (RPN1305X (ref. 66)). Probes were hybridized overnight
followed by post-hybridization washes and imaging of the FISH signals.
Imaging and image analysis. Immunoﬂuorescent images from whole-mount
embryos, heterologous zygotes, chromosome spreads and immuno-FISH on
in vitro decondensed spermatozoa were acquired using a Zeiss Axio Imager M2
confocal laser scanning microscope, equipped with four diode lasers (405, 488, 555,
639 nm), an Axiocam camera and Zen 2009 (Carl Zeiss) software. For embryos, we
recorded Z-series of 5 mm slices and for chromosome spreads, we recorded Z-series
of 0.5 mm slices. Images were processed with Image J (version 1.42n) and Adobe
Photoshop CS3 software.
Imaging for immuno-FISH on chromosome spreads was performed on a Zeiss
Axio Imager M1 microscope (Carl Zeiss), equipped with a CoolCube 1m camera
(MetaSystems) and Isis FISH Imaging System software (version 5.4.7,
MetaSystems). Images of immunoﬂuorescence and FISH were obtained in two
rounds of imaging and merged using Image J. With the ROI Manager in Image J, a
selected area of one image was copied to the other images. Subsequently, selected
areas were cropped and merged.
For visualization of co-localization between H3K9me3 and satellite DNA,
the distribution of ﬂuorescence intensities was plotted using the Straight lines
selection tool in Image J. Subsequently, using the Analyze—Plot Proﬁle tool, the
distribution of ﬂuorescence intensities along the selected line was obtained.
Sperm cells were divided into three categories according to their proﬁles for
H3K9me3 and satellite DNA: (1) proﬁles where the peak intensities for H3K9me3
and FISH signal completely overlap, (2) proﬁles where the peak intensities
are within a 1 mm distance and 3) proﬁles where the peak intensities are further
apart.
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